2021-01-08,My Best Biotech Stock for 2021
2021-01-06,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2021-01-06,Billionaire Andreas Halvorsens Top 10 Stock Picks
2021-01-05,3 Biotech Stocks That Could Double Your Money in 2021
2021-01-04,"EIDOS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of EIDX and Encourages Investors to Contact the Firm"
2021-01-04,Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote FOR Proposed Merger
2020-12-26,"Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, CIT, and EV"
2020-12-23,UCSF and BridgeBio Pharma Collaborate to Accelerate the Development of Therapies for Genetic Diseases
2020-12-19,"SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - BEAT, SNCA, BBIO, TLRY, NEOS"
2020-12-19,10 Best Biotech Stocks to Invest In According To Billionaire Biotech Hedge Fund
2020-12-17,"Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, EIDX, CIT, EMIS, FCNCA, FCNCB, EV, MS, NAV, STND, and WTRE"
2020-12-14,Is BBIO A Good Stock To Buy Now?
2020-12-14,Eidos Reportedly Received $4.6 Billion Takeover Bid From Glaxo
2020-12-11,Glaxo Bids $120 a Share for Eidos in Rival Offer
2020-12-07,BridgeBio Pharma and Maze Therapeutics Establish Joint Venture to Advance Precision Medicine to Treat Cardiovascular Disease
2020-12-04,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2020-12-04,"INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - WORK, WDR, BBIO, UROV, HDS"
2020-12-03,"Lifshitz Law Firm, P.C. Announces Investigation of BBIO, NAV, STND and WTRE"
2020-12-03,"Got $5,000 and 5 Years to Wait? Buy This Under-the-Radar Biotech Stock Now"
2020-12-02,"SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger"
2020-12-01,BridgeBio Pharma and Affiliate QED Therapeutics Announce FDA Acceptance of New Drug Application for Infigratinib for the Treatment of Cholangiocarcinoma
2020-11-25,"Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, BMCH, BLDR, CIT, EV, EIDX, NAV, STND and WTRE"
2020-11-13,BridgeBio Pharma and Affiliate Navire Pharma Announce Dosing of First Patient in Phase 1 Clinical Trial of SHP2 inhibitor BBP-398 for Tumors Driven by RAS and Receptor Tyrosine Kinase Mutations
2020-11-09,"SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigation of Eidos Therapeutics, Inc. Buyout"
2020-11-07,"Earnings Update: BridgeBio Pharma, Inc. (NASDAQ:BBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts"
2020-11-06,"Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Callaway Golf Company, Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., Watford Holdings Ltd. and Yintech Investment Holdings Limited"
2020-11-05,"BridgeBio Pharma (BBIO) Reports Q3 Loss, Misses Revenue Estimates"
2020-11-05,"BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business Update"
2020-11-04,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2020-10-29,Earnings Preview: BridgeBio Pharma (BBIO) Q3 Earnings Expected to Decline
2020-10-27,"MERGER ALERT - BSTC, BBIO, and PNM: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies"
2020-10-27,BridgeBio Pharma and Affiliate Phoenix Tissue Repair Announce First Patient Dosing In Phase 2 Trial of Protein Replacement Therapy for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
2020-10-23,"Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., MyoKardia, Inc. Watford Holdings Ltd. and Yintech Investment Holdings Limited"
2020-10-23,"MERGER ALERT - CIT, BBIO, and LSAC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies"
2020-10-21,"BridgeBio Pharma, Inc. and the University of Colorado Anschutz Medical Campus Collaborate to Advance Medicines for Genetically Driven Diseases"
2020-10-21,Salk Institute and BridgeBio Pharma Collaborate to Advance Therapies for Genetically Driven Disease
2020-10-16,"MERGER ALERT - WTRE, BBIO, and LSAC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies"
2020-10-15,"Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Cellular Biomedicine Group, Inc., and Eidos Therapeutics, Inc."
2020-10-07,"MERGER ALERT  GHIV, BBIO, and VRTU: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies"
2020-10-05,"SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Eidos Therapeutics, Inc. Buyout"
2020-10-05,"EIDOS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of EIDX and Encourages Investors to Contact the Firm"
2020-10-05,Why Eidos Therapeutics Stock Is Skyrocketing Today
2020-10-05,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of BridgeBio Pharma, Inc. with Eidos Therapeutics, Inc. is Fair to BBIO Shareholders"
2020-10-05,Eidos Shares Jump on Plan to Be Bought by BridgeBio
2020-10-05,(EIDX) Alert: Johnson Fistel Investigates Proposed Sale of Eidos Therapeutics; Are Shareholders Getting a Fair Deal?
2020-10-05,BridgeBio to buy Eidos Therapeutics in a cash and stock deal valuing Eidos at $2.8 billion
2020-10-05,BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement
2020-10-03,2 Under-the-Radar Biotech Stocks You'll Wish You Didn't Ignore
2020-09-29,BridgeBio Pharma Gets FDA OK For New Drug Application; BBIO Stock Up
2020-09-29,BridgeBio Pharma and Affiliate Origin Biosciences Announces FDA Acceptance of its New Drug Application for Fosdenopterin for the Treatment of MoCD Type A
2020-09-22,"BridgeBio Pharma to Host Virtual R&D Day on September 29, 2020"
2020-09-22,"Analysts Are Betting On BridgeBio Pharma, Inc. (NASDAQ:BBIO) With A Big Upgrade This Week"
2020-09-21,BridgeBio Pharmas Calcilytix Therapeutics Initiates Phase 2 Study Of Encaleret For Autosomal Dominant Hypocalcemia Type 1 (ADH1)
2020-09-03,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2020-08-12,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2020-08-11,"BridgeBio Pharma, Inc. Reports Second Quarter 2020 Financial Results and Business Update"
2020-08-11,"BridgeBio Pharma Expands Reach Into China and Other Major Asian Markets Through Strategic Collaboration With Perceptive Advisors-Founded Company, LianBio"
2020-07-28,Ivy Brain Tumor Center and BridgeBio Pharmas QED Therapeutics Announce Dosing of First Patient in Investigator-Initiated Phase 0/2 Clinical Trial of Infigratinib in Recurrent Glioblastoma
2020-07-15,BridgeBio Pharmas QED Therapeutics Doses First Child in Phase 2 Clinical Trial of the Investigational Medicine Infigratinib in Achondroplasia
2020-07-10,BridgeBio Pharmas Phoenix Tissue Repair to Highlight Interim Phase 1/2 Study Data in a Presentation at the Society for Pediatric Dermatologys 45th Annual Meeting
2020-07-06,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2020-07-05,"Hedge Funds Are Nibbling On BridgeBio Pharma, Inc. (BBIO)"
2020-06-25,"Benzinga's Top Upgrades, Downgrades For June 25, 2020"
2020-06-24,"BridgeBio Pharma, Inc. Appoints Biotech Trailblazers Brent Saunders and Randy Scott and Renowned Economist Andrew Lo to Board of Directors"
2020-06-18,BridgeBio Pharma and University of Florida Establish Collaboration to Advance Therapies for Genetically Driven Diseases
2020-06-18,"BridgeBio Pharma, Inc. Enters Into Collaboration Agreement With Johns Hopkins University to Accelerate Development of New Medicines in Genetically Driven Diseases"
2020-06-11,BridgeBio Pharmas ML Bio Solutions Announces Dosing of First Subject in Phase 1 Clinical Trial of BBP-418 For Limb Girdle Muscular Dystrophy Type 2i (LGMD2i)
2020-06-05,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2020-06-05,7 Growth Stocks to Buy for Oodles of Upside
2020-05-29,BridgeBio Pharmas QED Therapeutics Presents Data on Infigratinib in Cholangiocarcinoma and Urothelial Carcinoma at the American Society of Clinical Oncology 2020 Virtual Scientific Program
2020-05-19,21 Risky Stocks That Might Have Borrowed More Than Is Good For Them
2020-05-13,BridgeBio Pharmas Phoenix Tissue Repair Provides Updates to its Recessive Dystrophic Epidermolysis Bullosa (RDEB) Program and Announces New Leadership Appointments
2020-05-13,"BridgeBio Pharma, Inc. Reports First Quarter 2020 Financial Results and Business Update"
2020-05-11,BridgeBio Pharmas QED Therapeutics Announces Preclinical Data Demonstrating Potential of Low-Dose Infigratinib in Achondroplasia
2020-05-06,"BridgeBio Pharma, Inc. To Present At Upcoming Investor Conference"
2020-05-05,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2020-04-08,Why BridgeBio (BBIO) Stock Might be a Great Pick
2020-04-06,"Is BridgeBio Pharma, Inc. (BBIO) A Good Stock To Buy?"
2020-04-03,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2020-03-12,BridgeBio Pharmas QED Therapeutics Announces Dosing of First Patients in Phase 3 and Phase 2 Clinical Trials of Infigratinib in Tumors with FGFR Genetic Alterations
2020-03-04,"BridgeBio Pharma, Inc. Prices Upsized Offering of $475 Million Convertible Senior Notes"
2020-03-04,"BridgeBio Pharma, Inc. Announces Proposed Offering of $350 Million Convertible Senior Notes"
2020-03-03,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2020-03-02,BridgeBio Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Portfolio Progress
2020-02-24,"BridgeBio Pharma, Inc. Appoints Ronald J. Daniels To Its Board of Directors"
2020-02-21,BridgeBio Pharma And Eidos Therapeutics To Present At Upcoming Investor Conferences
2020-02-05,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2020-01-13,BridgeBio Pharma Grows Pipeline to 20+ Genetic Medicines with Four Assets Focused on Treating Genetically Driven Diseases at Their Source
2020-01-10,BridgeBio Pharmas Gene Therapy Subsidiaries Enter Strategic Partnership with Catalent for Dedicated Gene Therapy Development and Manufacturing Capacity
2020-01-08,PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel for People With High Frequency Basal Cell Carcinoma
2020-01-06,BridgeBio Pharmas QED Therapeutics Receives Fast Track Designation for Infigratinib in Adults with First-Line Advanced or Metastatic Cholangiocarcinoma and Orphan Drug Designation for Infigratinib for Treatment of Cholangiocarcinoma
2019-12-19,"BridgeBio Pharma, Inc. to Present at Upcoming Investor Conference"
2019-12-18,BridgeBio Pharmas Origin Biosciences Enters Partnership With Medison to Commercialize BBP-870 in Israel for MoCD Type A
2019-12-17,The 5 top performing IPOs of 2019
2019-12-16,"BridgeBio Pharma, Inc. Appoints Industry Leader Jennifer Cook as New Board Member"
2019-12-13,"BridgeBio Pharma, Inc. (BBIO): Are Hedge Funds Right About This Stock?"
2019-12-10,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares"
2019-12-09,"BridgeBio Pharma, Inc. Appoints Eli Wallace as Chief Scientific Officer in Residence for Oncology Programs"
2019-12-05,BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2019-12-03,BridgeBio Pharmas Origin Biosciences Initiates Rolling Submission of New Drug Application with the U.S. FDA for BBP-870 for the Treatment of MoCD Type A
